Page 5 - Technology Development Board News Today

The first nasal vaccine manufactured in India, called "iNCOVACC," will be introduced on Thursday by Union Health Minister Dr. Mansukh Mandaviya.

Bharat Biotechs iNCOVACC will be the country of Indias first needleless booster shot which will be available in private hospitals.

Bharat Biotech has introduced iNCOVACC (BBV154) as a booster dosage in the nation.

Bharat Biotech on Tuesday announced that its intranasal covid heterologous booster  iNCOVACC️ (BBV154) is scheduled to be introduced in the country in the fourth week of January and will cost Rs 800 privately and Rs 325 for large central and state government procurements.

The intranasal vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments,

INCOVACC is now available on CoWin, and priced at Rs 800 for private markets and priced at Rs 325 for supplies to government of India and state governments.

AMROHA (UP), December 27 : Addressing Venkateshwara University students here, Union Minister Dr Jitendra Singh today said that the Government headed by PM Narendra Modi has, in the last over 8 years, created futuristic avenues for India’s youth. Speaking at the University programme,“A Dialogue with New Young Voters” at the Venkateshwara University here,Dr Jitendra Singh said, the forward-looking reforms unleashed by Narendra Modi Government has given a new hope to the youth. He said, India...

The vaccine, iNCOVACC (BBV154), is now available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and state governments, the Hyderabad-based company said.Last

INCOVACC is to be priced at INR 325 per dose for large volume procurement by State Governments and Govt of India, and INR 800 for Private Markets.

Get latest articles and stories on India at LatestLY. iNCOVACC, on Tuesday, became the worlds first intra-nasal vaccine to receive both Primary series and Heterologous booster approval, Bharat Biotech International Limited (BBIL) announced India News | India-made INCOVACC, Worlds First Intra-nasal Vaccine to Receive Approval for Both Primary Series, Heterologous Booster.